{
  "docId": "019de077-6f73-7101-bfe0-7e9b852b36c0",
  "docSlug": "8dcc88c54610c972f3bae6a00c8c2119",
  "documentTitle": "MindMed | Investor Presentation Deck | 28 slides",
  "authorId": "mindmed",
  "authorName": "MindMed",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2025-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 13,
  "pageCount": 28,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "The slide outlines a multi-arm clinical development strategy with standardized trial designs (Part A/B) across different indications.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-6f73-7101-bfe0-7e9b852b36c0/13",
  "deckHref": "/decks/019de077-6f73-7101-bfe0-7e9b852b36c0",
  "deckJsonHref": "/decks/019de077-6f73-7101-bfe0-7e9b852b36c0.json",
  "deckAnchorHref": "/decks/019de077-6f73-7101-bfe0-7e9b852b36c0#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.64,
        "x": 0.18,
        "y": 0.14
      },
      "kind": "callout",
      "text": "Aligned clinical trial designs across indications maximize operational efficiencies",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8f4affb4-aedb-4064-9c4d-4018dc3e7237",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.68,
        "x": 0.16,
        "y": 0.92
      },
      "kind": "disclaimer",
      "text": "Studies will employ an adaptive design with interim blinded sample size re-estimation... DB: double blind; ODT: orally disintegrating tablet; OL: open-label; RCT: randomized controlled trial; HAM-A: Hamilton Anxiety Scale; MADRS: Montgomery-Åsberg Depression Rating Scale",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "09f20a9e-1c8b-42a3-bd23-3b75bc8c8e04",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.9,
        "x": 0.05,
        "y": 0.27
      },
      "kind": "list",
      "text": "Generalized Anxiety Disorder (GAD) vs Major Depressive Disorder (MDD)",
      "attrs": null,
      "subkind": "comparison",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "44c7bd4f-ebcb-4e8a-8c61-b73193e6fbd1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.85,
        "x": 0.03,
        "y": 0.04
      },
      "kind": "title",
      "text": "Robust Phase 3 MM120 Development Program Aiming for Broad Label",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d3fac23a-e54c-4751-8222-d008d499650e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "clinical-trial-design",
      "slug": null,
      "matchId": "6524a0b5-02c1-4f0a-ba2f-c77544a24778",
      "evidence": "Structured presentation of trial phases, endpoints, and patient cohorts",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}